Mineralys Therapeutics, Inc. (MLYS)
Mineralys Therapeutics, Inc. (MLYS) Insider Trading
Directors, officers and holders of more than 10% of MLYS report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 323 transactions on file: 0 with code P, 17 with code S and 33 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 19, 2026 | COATS LONNEL | Director | A Award | 12,400 | Not measured | Not measured |
| Oct 19, 2026 | Peterson Kristine | Director | A Award | 12,400 | Not measured | Not measured |
| Oct 19, 2026 | Peterson Kristine | Director | A Award | 16,600 | Not measured | Not measured |
| Oct 19, 2026 | COATS LONNEL | Director | A Award | 16,600 | Not measured | Not measured |
| Sep 30, 2026 | Congleton Jon | Chief Executive Officer | S Sale | 75,000 | $25.46 | $1,909,665 |
| Sep 22, 2026 | Slingsby Brian Taylor | Director | S Sale | 104,320 | $28.81 | $3,005,303 |
| Sep 21, 2026 | Warren Eric | Chief Commercial Officer | S Sale | 7,438 | $28.12 | $209,136 |
| Sep 21, 2026 | Warren Eric | Chief Commercial Officer | M Exercise | 7,438 | $13.24 | $98,479 |
| Sep 21, 2026 | Warren Eric | Chief Commercial Officer | M Exercise | 7,438 | Not measured | Not measured |
| Sep 15, 2026 | Karydas Daphne | Director | M Exercise | 3,000 | $12.02 | $36,060 |
| Sep 15, 2026 | Karydas Daphne | Director | S Sale | 3,000 | $28.58 | $85,740 |
| Sep 15, 2026 | Karydas Daphne | Director | M Exercise | 3,000 | Not measured | Not measured |
| Aug 21, 2026 | Warren Eric | Chief Commercial Officer | S Sale | 7,437 | $25.98 | $193,189 |
| Aug 21, 2026 | Warren Eric | Chief Commercial Officer | M Exercise | 7,437 | Not measured | Not measured |
| Aug 21, 2026 | Warren Eric | Chief Commercial Officer | M Exercise | 7,437 | $13.24 | $98,466 |
| Aug 10, 2026 | Rodman David Malcom | Chief Medical Officer | M Exercise | 2,170 | $16.00 | $34,720 |
| Aug 10, 2026 | Rodman David Malcom | Chief Medical Officer | M Exercise | 2,170 | Not measured | Not measured |
| Aug 10, 2026 | Rodman David Malcom | Chief Medical Officer | S Sale | 2,170 | $27.09 | $58,785 |
| Aug 10, 2026 | Ferguson James J. III | Chief Medical Officer | A Award | 102,400 | Not measured | Not measured |
| Aug 10, 2026 | Ferguson James J. III | Chief Medical Officer | A Award | 135,000 | Not measured | Not measured |
| Jul 21, 2026 | Warren Eric | Chief Commercial Officer | M Exercise | 7,438 | Not measured | Not measured |
| Jul 21, 2026 | Warren Eric | Chief Commercial Officer | S Sale | 7,438 | $26.87 | $199,885 |
| Jul 21, 2026 | Warren Eric | Chief Commercial Officer | M Exercise | 7,438 | $13.24 | $98,479 |
| Jul 17, 2026 | Rodman David Malcom | Chief Medical Officer | S Sale | 416 | $26.53 | $11,036 |
| Jul 17, 2026 | Rodman David Malcom | Chief Medical Officer | M Exercise | 416 | Not measured | Not measured |
| Jul 17, 2026 | Rodman David Malcom | Chief Medical Officer | M Exercise | 416 | $15.44 | $6,423 |
| Jul 15, 2026 | Rodman David Malcom | Chief Medical Officer | S Sale | 6,349 | $26.61 | $168,955 |
| Jul 13, 2026 | Rodman David Malcom | Chief Medical Officer | M Exercise | 6,349 | $1.08 | $6,857 |
| Jul 13, 2026 | Rodman David Malcom | Chief Medical Officer | M Exercise | 4,167 | $14.25 | $59,380 |
| Jul 13, 2026 | Rodman David Malcom | Chief Medical Officer | M Exercise | 3,542 | Not measured | Not measured |
| Jul 13, 2026 | Rodman David Malcom | Chief Medical Officer | M Exercise | 4,167 | Not measured | Not measured |
| Jul 13, 2026 | Rodman David Malcom | Chief Medical Officer | S Sale | 14,058 | $27.58 | $387,717 |
| Jul 13, 2026 | Congleton Jon | Chief Executive Officer | S Sale | 10,700 | $27.24 | $291,441 |
| Jul 13, 2026 | Rodman David Malcom | Chief Medical Officer | M Exercise | 3,542 | $10.20 | $36,128 |
| Jul 13, 2026 | Rodman David Malcom | Chief Medical Officer | M Exercise | 6,349 | Not measured | Not measured |
| Jul 9, 2026 | Rodman David Malcom | Chief Medical Officer | M Exercise | 2,171 | Not measured | Not measured |
| Jul 9, 2026 | Rodman David Malcom | Chief Medical Officer | S Sale | 2,171 | $30.30 | $65,781 |
| Jul 9, 2026 | Rodman David Malcom | Chief Medical Officer | M Exercise | 2,171 | $16.00 | $34,736 |
| Jun 30, 2026 | Congleton Jon | Chief Executive Officer | S Sale | 17,000 | $26.82 | $455,896 |
| Jun 30, 2026 | Congleton Jon | Chief Executive Officer | S Sale | 58,000 | $25.94 | $1,504,706 |
| Jun 26, 2026 | Warren Eric | Chief Commercial Officer | M Exercise | 104,124 | $13.24 | $1,378,602 |
| Jun 26, 2026 | Warren Eric | Chief Commercial Officer | M Exercise | 104,124 | Not measured | Not measured |
| Jun 26, 2026 | Warren Eric | Chief Commercial Officer | S Sale | 104,124 | $25.90 | $2,696,322 |
| Jun 17, 2026 | Karydas Daphne | Director | S Sale | 3,000 | $25.00 | $75,000 |
| Jun 17, 2026 | Karydas Daphne | Director | M Exercise | 3,000 | $12.02 | $36,060 |
| Jun 17, 2026 | Rodman David Malcom | Chief Medical Officer | M Exercise | 417 | Not measured | Not measured |
| Jun 17, 2026 | Karydas Daphne | Director | M Exercise | 3,000 | Not measured | Not measured |
| Jun 17, 2026 | Rodman David Malcom | Chief Medical Officer | S Sale | 4,584 | $25.00 | $114,600 |
| Jun 17, 2026 | Rodman David Malcom | Chief Medical Officer | M Exercise | 417 | $15.44 | $6,438 |
| Jun 17, 2026 | Rodman David Malcom | Chief Medical Officer | M Exercise | 4,167 | $14.25 | $59,380 |
The full Form 4 history is on the MLYS company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.